*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| C9002 - Multiple myeloma in relapse - as a primary diagnosis code | C9002 - Multiple myeloma in relapse - as a primary or secondary diagnosis code | |
|---|---|---|
| OUTCOMES | ||
| Avg. LOS | 8.16 | |
| Readmission Rate (%) | 36.48 | |
| Unplanned Readmission Rate (%) | 22.2 | |
| Mortality Rate (%) | ||
| SNF Discharge Rate (%) | ||
| Home Discharge Rate (%) | ||
| PAYMENTS AND CHARGES | ||
| Total Medicare Payments | ||
| Payment Per Day | ||
| Payment Per Hospitalization | ||
| Total Medicare Charges | ||
| Avg. Charges | ||
| MARKET SIZING & INCIDENCE RATES | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - All) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations after Exclusion | ||
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 840: LYMPHOMA AND NON-ACUTE LEUKEMIA WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 841: LYMPHOMA AND NON-ACUTE LEUKEMIA WITH COMPLICATION OR COMORBIDITY (CC) | DRG 016: AUTOLOGOUS BONE MARROW TRANSPLANT WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 823: LYMPHOMA AND NON-ACUTE LEUKEMIA WITH OTHER O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 842: LYMPHOMA AND NON-ACUTE LEUKEMIA WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 29,081 | ||||
| Total Hospitalizations with ICD C9002 - Multiple myeloma in relapse | 1,181 | ||||
| DRG Share of Total Hospitalizations | 0.09 | ||||
| % of Total ICD C9002 - Multiple myeloma in relapse in DRG | 43.87 | ||||
| Avg LOS at DRG | 9.8 | ||||
| Avg LOS with ICD C9002 - Multiple myeloma in relapse | 11.46 | ||||
| Readmission Rate at DRG | 37.3 | ||||
| Readmission Rate with ICD C9002 - Multiple myeloma in relapse | 41.11 | ||||
| Unplanned Readmission Rate at DRG | 22.57 | ||||
| Unplanned Readmission Rate with ICD C9002 - Multiple myeloma in relapse | 24.27 | ||||
| Total Medicare payments at DRG | $683,745,757 | ||||
| Total Medicare payments with ICD C9002 - Multiple myeloma in relapse | $31,810,235 | ||||
| Total Medicare payment per Day at DRG | $2,399 | ||||
| Total Medicare payment per Day with ICD C9002 - Multiple myeloma in relapse | $2,351 | ||||
| Total Medicare payment per Hospitalization at DRG | $23,512 | ||||
| Total Medicare payment per Hospitalization with ICD C9002 - Multiple myeloma in relapse | $26,935 | ||||
| Total Medicare Charges at DRG | $3,049,100,784 | ||||
| Total Medicare Charges with ICD C9002 - Multiple myeloma in relapse | $148,251,434 | ||||
| Avg Charges at DRG | $104,849 | ||||
| Avg Charges with ICD C9002 - Multiple myeloma in relapse | $125,530 | ||||
| Mortality Rate at DRG | 13.07 | ||||
| Mortality Rate with ICD C9002 - Multiple myeloma in relapse | 14.31 | ||||
| SNF Discharge Rate at DRG | 16.93 | ||||
| SNF Discharge Rate with ICD C9002 - Multiple myeloma in relapse | 12.79 | ||||
| Home Discharge Rate at DRG | 29.4 | ||||
| Home Discharge Rate with ICD C9002 - Multiple myeloma in relapse | 33.19 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 824: LYMPHOMA AND NON-ACUTE LEUKEMIA WITH OTHER O.R. PROCEDURE WITH COMPLICATION OR COMORBIDITY (CC) | DRG 821: LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURE WITH COMPLICATION OR COMORBIDITY (CC) | DRG 820: LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 014: ALLOGENEIC BONE MARROW TRANSPLANT | DRG 017: AUTOLOGOUS BONE MARROW TRANSPLANT WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 7,492 | ||||
| Total Hospitalizations with ICD C9002 - Multiple myeloma in relapse | 75 | ||||
| DRG Share of Total Hospitalizations | 0.02 | ||||
| % of Total ICD C9002 - Multiple myeloma in relapse in DRG | 2.79 | ||||
| Avg LOS at DRG | 6.91 | ||||
| Avg LOS with ICD C9002 - Multiple myeloma in relapse | 6.67 | ||||
| Readmission Rate at DRG | 34.67 | ||||
| Readmission Rate with ICD C9002 - Multiple myeloma in relapse | 32.43 | ||||
| Unplanned Readmission Rate at DRG | 20.6 | ||||
| Unplanned Readmission Rate with ICD C9002 - Multiple myeloma in relapse | 24.32 | ||||
| Total Medicare payments at DRG | $118,497,705 | ||||
| Total Medicare payments with ICD C9002 - Multiple myeloma in relapse | $1,327,497 | ||||
| Total Medicare payment per Day at DRG | $2,288 | ||||
| Total Medicare payment per Day with ICD C9002 - Multiple myeloma in relapse | $2,655 | ||||
| Total Medicare payment per Hospitalization at DRG | $15,817 | ||||
| Total Medicare payment per Hospitalization with ICD C9002 - Multiple myeloma in relapse | $17,700 | ||||
| Total Medicare Charges at DRG | $621,975,834 | ||||
| Total Medicare Charges with ICD C9002 - Multiple myeloma in relapse | $7,377,320 | ||||
| Avg Charges at DRG | $83,019 | ||||
| Avg Charges with ICD C9002 - Multiple myeloma in relapse | $98,364 | ||||
| Mortality Rate at DRG | 0.85 | ||||
| Mortality Rate with ICD C9002 - Multiple myeloma in relapse | NA | ||||
| SNF Discharge Rate at DRG | 12.76 | ||||
| SNF Discharge Rate with ICD C9002 - Multiple myeloma in relapse | 20.0 | ||||
| Home Discharge Rate at DRG | 56.85 | ||||
| Home Discharge Rate with ICD C9002 - Multiple myeloma in relapse | 44.0 |
| Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | 166 |
| UAMS MEDICAL CENTER | 4301 W MARKHAM ST | LITTLE ROCK | AR | 72205 | 118 |
| MEMORIAL SLOAN KETTERING CANCER CENTER | 1275 YORK AVE | NEW YORK | NY | 10065 | 71 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| Dr. SHEEBA KOSHY THOMAS | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | 23 |
| Dr. PANKAJ MATHUR | 4301 W MARKHAM ST # 783 | LITTLE ROCK | AR | 72205 | 19 |
| Dr. DONNA M. WEBER | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | 17 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| Dr. SHEEBA KOSHY THOMAS | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | 31 |
| Dr. PANKAJ MATHUR | 4301 W MARKHAM ST # 783 | LITTLE ROCK | AR | 72205 | 30 |
| Dr. ELISABET MANASANCH | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | 25 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 840: LYMPHOMA AND NON-ACUTE LEUKEMIA WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 841: LYMPHOMA AND NON-ACUTE LEUKEMIA WITH COMPLICATION OR COMORBIDITY (CC) | DRG 847: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 016: AUTOLOGOUS BONE MARROW TRANSPLANT WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 29,081 | ||||
| Total Hospitalizations with ICD C9002 - Multiple myeloma in relapse | 1,223 | ||||
| DRG Share of Total Hospitalizations | 0.09 | ||||
| % of Total ICD C9002 - Multiple myeloma in relapse in DRG | 10.77 | ||||
| Avg LOS at DRG | 9.8 | ||||
| Avg LOS with ICD C9002 - Multiple myeloma in relapse | 11.43 | ||||
| Readmission Rate at DRG | 37.3 | ||||
| Readmission Rate with ICD C9002 - Multiple myeloma in relapse | 41.13 | ||||
| Unplanned Readmission Rate at DRG | 22.57 | ||||
| Unplanned Readmission Rate with ICD C9002 - Multiple myeloma in relapse | 23.99 | ||||
| Total Medicare payments at DRG | $683,745,757 | ||||
| Total Medicare payments with ICD C9002 - Multiple myeloma in relapse | $32,986,627 | ||||
| Total Medicare payment per Day at DRG | $2,399 | ||||
| Total Medicare payment per Day with ICD C9002 - Multiple myeloma in relapse | $2,359 | ||||
| Total Medicare payment per Hospitalization at DRG | $23,512 | ||||
| Total Medicare payment per Hospitalization with ICD C9002 - Multiple myeloma in relapse | $26,972 | ||||
| Total Medicare Charges at DRG | $3,049,100,784 | ||||
| Total Medicare Charges with ICD C9002 - Multiple myeloma in relapse | $154,578,428 | ||||
| Avg Charges at DRG | $104,849 | ||||
| Avg Charges with ICD C9002 - Multiple myeloma in relapse | $126,393 | ||||
| Mortality Rate at DRG | 13.07 | ||||
| Mortality Rate with ICD C9002 - Multiple myeloma in relapse | 14.06 | ||||
| SNF Discharge Rate at DRG | 16.93 | ||||
| SNF Discharge Rate with ICD C9002 - Multiple myeloma in relapse | 12.76 | ||||
| Home Discharge Rate at DRG | 29.4 | ||||
| Home Discharge Rate with ICD C9002 - Multiple myeloma in relapse | 33.44 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 846: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 194: SIMPLE PNEUMONIA AND PLEURISY WITH COMPLICATION OR COMORBIDITY (CC) | DRG 193: SIMPLE PNEUMONIA AND PLEURISY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 809: MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 11,287 | ||||
| Total Hospitalizations with ICD C9002 - Multiple myeloma in relapse | 392 | ||||
| DRG Share of Total Hospitalizations | 0.03 | ||||
| % of Total ICD C9002 - Multiple myeloma in relapse in DRG | 3.45 | ||||
| Avg LOS at DRG | 8.09 | ||||
| Avg LOS with ICD C9002 - Multiple myeloma in relapse | 10.0 | ||||
| Readmission Rate at DRG | 63.47 | ||||
| Readmission Rate with ICD C9002 - Multiple myeloma in relapse | 53.7 | ||||
| Unplanned Readmission Rate at DRG | 16.01 | ||||
| Unplanned Readmission Rate with ICD C9002 - Multiple myeloma in relapse | 21.92 | ||||
| Total Medicare payments at DRG | $252,996,223 | ||||
| Total Medicare payments with ICD C9002 - Multiple myeloma in relapse | $9,066,677 | ||||
| Total Medicare payment per Day at DRG | $2,772 | ||||
| Total Medicare payment per Day with ICD C9002 - Multiple myeloma in relapse | $2,314 | ||||
| Total Medicare payment per Hospitalization at DRG | $22,415 | ||||
| Total Medicare payment per Hospitalization with ICD C9002 - Multiple myeloma in relapse | $23,129 | ||||
| Total Medicare Charges at DRG | $1,139,315,524 | ||||
| Total Medicare Charges with ICD C9002 - Multiple myeloma in relapse | $48,587,112 | ||||
| Avg Charges at DRG | $100,941 | ||||
| Avg Charges with ICD C9002 - Multiple myeloma in relapse | $123,947 | ||||
| Mortality Rate at DRG | 3.42 | ||||
| Mortality Rate with ICD C9002 - Multiple myeloma in relapse | 4.34 | ||||
| SNF Discharge Rate at DRG | 9.94 | ||||
| SNF Discharge Rate with ICD C9002 - Multiple myeloma in relapse | 3.32 | ||||
| Home Discharge Rate at DRG | 62.95 | ||||
| Home Discharge Rate with ICD C9002 - Multiple myeloma in relapse | 72.45 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 808: MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 640: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 365,119 | ||||
| Total Hospitalizations with ICD C9002 - Multiple myeloma in relapse | 271 | ||||
| DRG Share of Total Hospitalizations | 1.11 | ||||
| % of Total ICD C9002 - Multiple myeloma in relapse in DRG | 2.39 | ||||
| Avg LOS at DRG | 5.91 | ||||
| Avg LOS with ICD C9002 - Multiple myeloma in relapse | 8.62 | ||||
| Readmission Rate at DRG | 27.73 | ||||
| Readmission Rate with ICD C9002 - Multiple myeloma in relapse | 38.14 | ||||
| Unplanned Readmission Rate at DRG | 20.3 | ||||
| Unplanned Readmission Rate with ICD C9002 - Multiple myeloma in relapse | 25.0 | ||||
| Total Medicare payments at DRG | $3,552,910,533 | ||||
| Total Medicare payments with ICD C9002 - Multiple myeloma in relapse | $3,804,192 | ||||
| Total Medicare payment per Day at DRG | $1,646 | ||||
| Total Medicare payment per Day with ICD C9002 - Multiple myeloma in relapse | $1,629 | ||||
| Total Medicare payment per Hospitalization at DRG | $9,731 | ||||
| Total Medicare payment per Hospitalization with ICD C9002 - Multiple myeloma in relapse | $14,038 | ||||
| Total Medicare Charges at DRG | $16,860,985,198 | ||||
| Total Medicare Charges with ICD C9002 - Multiple myeloma in relapse | $22,061,160 | ||||
| Avg Charges at DRG | $46,179 | ||||
| Avg Charges with ICD C9002 - Multiple myeloma in relapse | $81,406 | ||||
| Mortality Rate at DRG | 5.06 | ||||
| Mortality Rate with ICD C9002 - Multiple myeloma in relapse | 6.27 | ||||
| SNF Discharge Rate at DRG | 28.7 | ||||
| SNF Discharge Rate with ICD C9002 - Multiple myeloma in relapse | 16.61 | ||||
| Home Discharge Rate at DRG | 32.16 | ||||
| Home Discharge Rate with ICD C9002 - Multiple myeloma in relapse | 41.33 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 853: INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 641: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 823: LYMPHOMA AND NON-ACUTE LEUKEMIA WITH OTHER O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 842: LYMPHOMA AND NON-ACUTE LEUKEMIA WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 948: SIGNS AND SYMPTOMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 269,064 | ||||
| Total Hospitalizations with ICD C9002 - Multiple myeloma in relapse | 129 | ||||
| DRG Share of Total Hospitalizations | 0.82 | ||||
| % of Total ICD C9002 - Multiple myeloma in relapse in DRG | 1.14 | ||||
| Avg LOS at DRG | 13.18 | ||||
| Avg LOS with ICD C9002 - Multiple myeloma in relapse | 14.85 | ||||
| Readmission Rate at DRG | 37.51 | ||||
| Readmission Rate with ICD C9002 - Multiple myeloma in relapse | 45.54 | ||||
| Unplanned Readmission Rate at DRG | 18.15 | ||||
| Unplanned Readmission Rate with ICD C9002 - Multiple myeloma in relapse | 18.81 | ||||
| Total Medicare payments at DRG | $9,344,186,034 | ||||
| Total Medicare payments with ICD C9002 - Multiple myeloma in relapse | $5,326,383 | ||||
| Total Medicare payment per Day at DRG | $2,635 | ||||
| Total Medicare payment per Day with ICD C9002 - Multiple myeloma in relapse | $2,780 | ||||
| Total Medicare payment per Hospitalization at DRG | $34,728 | ||||
| Total Medicare payment per Hospitalization with ICD C9002 - Multiple myeloma in relapse | $41,290 | ||||
| Total Medicare Charges at DRG | $44,371,117,432 | ||||
| Total Medicare Charges with ICD C9002 - Multiple myeloma in relapse | $25,999,968 | ||||
| Avg Charges at DRG | $164,909 | ||||
| Avg Charges with ICD C9002 - Multiple myeloma in relapse | $201,550 | ||||
| Mortality Rate at DRG | 14.37 | ||||
| Mortality Rate with ICD C9002 - Multiple myeloma in relapse | 19.38 | ||||
| SNF Discharge Rate at DRG | 31.8 | ||||
| SNF Discharge Rate with ICD C9002 - Multiple myeloma in relapse | 17.83 | ||||
| Home Discharge Rate at DRG | 14.61 | ||||
| Home Discharge Rate with ICD C9002 - Multiple myeloma in relapse | 18.6 |
| Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | 399 |
| UAMS MEDICAL CENTER | 4301 W MARKHAM ST | LITTLE ROCK | AR | 72205 | 317 |
| MEMORIAL SLOAN KETTERING CANCER CENTER | 1275 YORK AVE | NEW YORK | NY | 10065 | 251 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| Dr. SHEEBA KOSHY THOMAS | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | 67 |
| Dr. ELISABET MANASANCH | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | 47 |
| Dr. DONNA M. WEBER | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | 46 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| Dr. SHEEBA KOSHY THOMAS | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | 81 |
| Dr. ELISABET MANASANCH | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | 65 |
| Dr. DONNA M. WEBER | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | 57 |